Dianthus Therapeutics Inc. Capital Reinvestment Ratio

Latest as of September 2023: 0.10x

Dianthus Therapeutics Inc. capital reinvestment ratio. Dianthus Therapeutics Inc. (DNTH) has a Capital Reinvestment Ratio of 0.10x as of September 2023, meaning it reinvests 0% of its operating cash flow ($1.50 Million) in capital expenditures ($145.00K). Check Dianthus Therapeutics Inc. (DNTH) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.10x

Capex / Operating Cash Flow

Operating Cash Flow

$1.50 Million

USD

Capital Expenditures

$145.00K

USD

Data as of

Sep 2023

Most recent filing

Dianthus Therapeutics Inc. Capital Reinvestment Ratio by Year (None–None)

Dianthus Therapeutics Inc. capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Dianthus Therapeutics Inc. (DNTH) cash conversion ratio.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow